Teligent Opens Product Development Lab in Estonia
Complete the form below to unlock access to ALL audio articles.
Teligent Inc has announced that it has opened a pharmaceutical Product Development laboratory in Estonia. The GMP-compliant lab will support the development of topical and injectable pharmaceutical products for the company's North American markets.
The 3,000-square foot facility also includes administrative space for quality assurance and supply chain employees who oversee the company's third-party contract manufacturing activities around the world.
"We are excited to strengthen our R&D capabilities through the opening of this product development lab in Estonia," commented Jason Grenfell-Gardner, President and CEO of the Company. "We are impressed by the caliber of scientific talent available in the country, and look forward to this lab working closely with our R&D colleagues in New Jersey.''
The Company established its operation in Estonia in 2015, where it has been managing logistics and supply relationships between third-party suppliers and the US and Canadian markets. Grenfell-Gardner concluded, ''The opening of this lab for analytical method and formulation work is the next step in our journey to build pharmaceutical capabilities in our Estonia business.''
